-
1
المؤلفون: Cardone C., Blauensteiner B., Moreno-Viedma V., Martini G., Simeon V., Vitiello P. P., Ciardiello D., Belli V., Matrone N., Troiani T., Morgillo F., Zito Marino F., Dentice M., Nappi A., Boccaccino A., Antoniotti C., Cremolini C., Pietrantonio F., Prager G. W., Normanno N., Maiello E., Argiles G., Elez E., Signoriello G., Franco R., Falcone A., Tabernero J., Sibilia M., Ciardiello F., Martinelli E., ZITO MARINO, Federica
المساهمون: Cardone, Claudia, Blauensteiner, Bernadette, Moreno-Viedma, Veronica, Martini, Giulia, Simeon, Vittorio, Vitiello, Pietro P, Ciardiello, Davide, Belli, Valentina, Matrone, Nunzia, Troiani, Teresa, Morgillo, Floriana, Zito Marino, Federica, Dentice, Monica, Nappi, Annarita, Boccaccino, Alessandra, Antoniotti, Carlotta, Cremolini, Chiara, Pietrantonio, Filippo, Prager, Gerald W, Normanno, Nicola, Maiello, Evaristo, Argiles, Guillem, Elez, Elena, Signoriello, Giuseppe, Franco, Renato, Falcone, Alfredo, Tabernero, Josep, Sibilia, Maria, Ciardiello, Fortunato, Martinelli, Erika, Cardone, C., Blauensteiner, B., Moreno-Viedma, V., Martini, G., Simeon, V., Vitiello, P. P., Ciardiello, D., Belli, V., Matrone, N., Troiani, T., Morgillo, F., Zito Marino, F., Dentice, M., Nappi, A., Boccaccino, A., Antoniotti, C., Cremolini, C., Pietrantonio, F., Prager, G. W., Normanno, N., Maiello, E., Argiles, G., Elez, E., Signoriello, G., Franco, R., Falcone, A., Tabernero, J., Sibilia, M., Ciardiello, F., Martinelli, E., ZITO MARINO, Federica
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Colorectal cancer, Population, 03 medical and health sciences, Mice, 0302 clinical medicine, Growth factor receptor, Internal medicine, Cell Line, Tumor, Proto-Oncogene Proteins, Medicine, Animals, Humans, Epithelial–mesenchymal transition, Neoplasm Metastasis, education, education.field_of_study, Cetuximab, business.industry, AXL, EGFR resistance, RAS WT, Receptor Protein-Tyrosine Kinases, Transfection, medicine.disease, Xenograft Model Antitumor Assays, Axl Receptor Tyrosine Kinase, Blockade, ErbB Receptors, 030104 developmental biology, Genes, ras, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Immunohistochemistry, business, Colorectal Neoplasms, Biomarkers, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4937b3b9337afc85a90006c6268b2a74Test
https://hdl.handle.net/11588/920571Test -
2
المؤلفون: Ameri, P, Canepa, M, Anker, MS, Belenkov, Y, Bergler-Klein, J, Cohen-Solal, A, Farmakis, D, López-Fernández, T, Lainscak, M, Pudil, R, Ruschitska, F, Seferovic, P, Filippatos, G, Coats, A, Suter, T, Von Haehling, S, Ciardiello, F, De Boer, RA, Lyon, AR, Tocchetti, CG, Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology
المساهمون: Ameri, Pietro, Canepa, Marco, Anker, Markus S., Belenkov, Yury, Bergler-Klein, Jutta, Cohen-Solal, Alain, Farmakis, Dimitrio, López-Fernández, Teresa, Lainscak, Mitja, Pudil, Radek, Ruschitska, Frank, Seferovic, Petar, Filippatos, Gerasimo, Coats, Andrew, Suter, Thoma, Von Haehling, Stephan, Ciardiello, Fortunato, de Boer, Rudolf A., Lyon, Alexander R., Tocchetti, Carlo G.
المصدر: European Journal of Heart Failure. 20(5):879-887
مصطلحات موضوعية: Cardiac & Cardiovascular Systems, medicine.medical_treatment, Co-morbidity, Comorbidity, 030204 cardiovascular system & hematology, Global Health, Targeted therapy, Androgen deprivation therapy, Prostate cancer, 0302 clinical medicine, TARGETED THERAPY, RENAL-CELL CARCINOMA, Neoplasms, Epidemiology, INCREASED RISK, AMERICAN SOCIETY, Cancer, Heart failure, Prognosis, Therapy, Cardiology and Cardiovascular Medicine, ORAL ANTICOAGULANTS, Incidence (epidemiology), Incidence, Disease Management, 3. Good health, PROSTATE-CANCER, Survival Rate, PRACTICE GUIDELINES, 030220 oncology & carcinogenesis, Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology, Life Sciences & Biomedicine, Diagnostic Imaging, medicine.medical_specialty, Prognosi, LONG-TERM, Malignancy, 1102 Cardiovascular Medicine And Haematology, 03 medical and health sciences, Breast cancer, medicine, Humans, BREAST-CANCER, Intensive care medicine, TERM-FOLLOW-UP, EUROPEAN ASSOCIATION, Science & Technology, business.industry, medicine.disease, MYOCARDIAL-INFARCTION, Cardiovascular System & Hematology, ATRIAL-FIBRILLATION, Cardiovascular System & Cardiology, ANDROGEN DEPRIVATION THERAPY, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ae5221f0ca1c551bc118d061e00b74Test
https://hdl.handle.net/11370/4cad5946-19a3-4022-8749-fb5e2127683fTest -
3
المؤلفون: Van Cutsem, E, Yoshino, T, Lenz, H J, Lonardi, S, Falcone, A, Limón, M L, Saunders, M, Sobrero, A, Park, Y S, Ferreiro, R, Hong, Y S, Tomasek, J, Taniguchi, H, Ciardiello, F, Stoehr, J, Oum'Hamed, Z, Vlassak, S, Studeny, M, Argiles, G, Universitat Autònoma de Barcelona
المساهمون: Van Cutsem, E, Yoshino, T, Lenz, H J, Lonardi, S, Falcone, A, Limón, M L, Saunders, M, Sobrero, A, Park, Y S, Ferreiro, R, Hong, Y S, Tomasek, J, Taniguchi, H, Ciardiello, F, Stoehr, J, Oum'Hamed, Z, Vlassak, S, Studeny, M, Argiles, G
المصدر: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Annals of Oncologyمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Indoles, chemorefractory metastatic colorectal cancer, Placebo-controlled study, Administration, Oral, law.invention, Placebos, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, nintedanib, angiogenesis inhibition, Hematology, Fatigue, Hazard ratio, Middle Aged, Progression-Free Survival, Angiogenesis inhibition, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Disease Progression, Nintedanib, Female, Chemical and Drug Induced Liver Injury, Colorectal Neoplasms, Adult, medicine.medical_specialty, Antineoplastic Agents, Adenocarcinoma, Placebo, 03 medical and health sciences, Double-Blind Method, Internal medicine, Regorafenib, Gastrointestinal Tumors, medicine, Humans, Progression-free survival, Protein Kinase Inhibitors, neoplasms, Aged, business.industry, Chemorefractory metastatic colorectal cancer, Original Articles, digestive system diseases, 030104 developmental biology, Receptors, Vascular Endothelial Growth Factor, chemistry, business
وصف الملف: application/pdf; Print
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f41d65dc8d8674d58105961d203252feTest
https://hdl.handle.net/20.500.12530/36062Test -
4
المؤلفون: Popescu, R. A., Schäfer, R., Califano, R., Eckert, R., Coleman, R., Douillard, J.-Y., Cervantes, A., Casali, Paolo G., Sessa, Cristiana, Cutsem, E. van, Vries, Elisabeth G. E. de, Pavlidis, Nicholas, Fumasoli, K., Wörmann, B., Samonigg, H., Cascinu, S., Hernández, J. J. C., Howard, A. J., Ciardiello, F., Stahel, R. A., Piccart, M.
المساهمون: Popescu, Ra, Schäfer, R, Califano, R, Eckert, R, Coleman, R, Douillard, Jy, Cervantes, A, Casali, Pg, Sessa, C, Van Cutsem, E, de Vries, E, Pavlidis, N, Fumasoli, K, Wörmann, B, Samonigg, H, Cascinu, S, Cruz Hernández, Jj, Howard, Aj, Ciardiello, Fortunato, Stahel, Ra, Piccart, M., Popescu, R. A., Schäfer, R., Califano, R., Eckert, R., Coleman, R., Douillard, J. -Y., Cervantes, A., Casali, P. G., Sessa, C., van Cutsem, E., de Vries, E., Pavlidis, N., Fumasoli, K., Wörmann, B., Samonigg, H., Cascinu, S., Hernández, J. J. Cruz, Howard, A. J., Ciardiello, F., Stahel, R. A., University of Zurich, Popescu, R A, Pavlidis, Nicholas [0000-0002-2195-9961], Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Annals of Oncology
Annals of Oncology, 25(1), 9-15. Oxford University Pressمصطلحات موضوعية: Oncology, Political participation, Work environment, diagnosis, 2720 Hematology, Cancer prevention, Profession, Continuing medical education, Neoplasms, Health care, Diagnosis, Drug use, Priority journal, Evidence-Based Medicine, Cost effectiveness analysis, treatment, Medical oncologist, Professional development, Professional standard, Cancer diagnosis, Hematology, Professional practice, medical oncology, Europe, Patient safety, 2730 Oncology, Multidisciplinary team (MDT), multidisciplinary team (MDT), Diagnosi, Human, Quality of life, Medical education, medicine.medical_specialty, Medical oncology, education, Specialty, Translational research, 610 Medicine & health, Cancer research, Patient care, Article, Research, Treatment, Humans, Interdisciplinary Communication, Medical Oncology, Physician-Patient Relations, Quality of Health Care, Physician's Role, Nursing, Internal medicine, medicine, profession, research, Physician-Patient Relation, business.industry, Physician attitude, Cancer, Evidence-based medicine, Physician-patient relations, medicine.disease, Personalized medicine, Family medicine, Evidence based medicine, 10032 Clinic for Oncology and Hematology, Position paper, Cancer patient, Neoplasm, business
وصف الملف: Popescu et al_AoO_2014.pdf - application/pdf; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a972dbf1a5f90b570901fdde6bf09f0eTest
https://research.rug.nl/en/publications/d88c96b3-7f18-4463-ab46-c33e7ef4b95cTest -
5
المؤلفون: Peters S, Stahel RA, Dafni U, Ponce Aix S, Massutí B, Gautschi O, Coate L, López Martín A, van Heemst R, Berghmans T, Meldgaard P, Cobo Dols M, Garde Noguera J, Curioni-Fontecedro A, Rauch D, Mark MT, Cuffe S, Biesma B, van Henten AMJ, Juan Vidal Ó, Palmero Sanchez R, Villa Guzmán JC, Collado Martin R, Peralta S, Insa A, Summers Y, Láng I, Horgan A, Ciardiello F, de Hosson S, Pieterman R, Groen HJM, van den Berg PM, Zielinski CC, Chittazhathu Kurian Kuruvilla Y, Gasca-Ruchti A, Kassapian M, Novello S, Torri V, Tsourti Z, Gregorc V, Smit EF, EMPHASIS-lung Collaborative Group
المساهمون: Pulmonary medicine, CCA - Cancer Treatment and quality of life, Peters, S, Stahel, Ra, Dafni, U, Aix, Sp, Massutí, B, Gautschi, O, Coate, L, López Martín, A, Van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Noguera, Jg, Curioni Fontecedro, A, Rauch, D, Mark, Mt, Cuffe, S, Biesma, B, Van Henten, Am, Vidal, Ój, Sanchez, Rp, Villa Guzmán, Jc, Martin, Rc, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, Fortunato, De Hosson, S, Pieterman, R, Groen, Hj, Van Den Berg, Pm, Zielinski, Cc, Kuruvilla, Yc, Gasca Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, Ef, EMPHASIS lung collaborative, Group
المصدر: JOURNAL OF THORACIC ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Journal of Thoracic Oncology, 12(4), 752-762. International Association for the Study of Lung Cancer
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Journal of Thoracic Oncology, 12(4), 752-762. ELSEVIER SCIENCE INCمصطلحات موضوعية: Oncology, Male, Lung Neoplasms, medicine.medical_treatment, Docetaxel, NSCLC, THERAPY, Squamous, Cohort Studies, RETROSPECTIVE ANALYSIS, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, 3RD-LINE, Antineoplastic Combined Chemotherapy Protocols, VeriStrat, 030212 general & internal medicine, Erlotinib Hydrochloride, ETOP, Prognosis, Survival Rate, Erlotinib, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Taxoids, Veristrat, 2ND-LINE TREATMENT, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, 03 medical and health sciences, Internal medicine, Multicenter trial, medicine, TYROSINE KINASE INHIBITORS, Journal Article, Humans, Lung cancer, COMBINATION, Survival rate, neoplasms, METAANALYSIS, Aged, Neoplasm Staging, Platinum, Chemotherapy, business.industry, medicine.disease, respiratory tract diseases, business, GROWTH-FACTOR RECEPTOR, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee1d367d8bc33b24edc27d000909d5bdTest
https://pubmed.ncbi.nlm.nih.gov/28343541Test -
6
المؤلفون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, Ms, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigators, Calabro', L
المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C., Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Leighl, Nb
مصطلحات موضوعية: Oncology, Male, erlotinib, Lung Neoplasms, Health-related quality of life, NSCLC, chemotherapy, Deoxycytidine, law.invention, Randomized controlled trial, Quality of life, law, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Surveys and Questionnaire, Quality of life analysis of TORCH, Erlotinib Hydrochloride, Prognosis, humanities, Research Design, Advanced non–small-cell lung cancer, Carcinoma, Squamous Cell, Female, Erlotinib, Randomized trial, medicine.drug, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Prognosi, EGFR, First-line treatment, first-line erlotinib, second-line cisplatin/gemcitabine chemotherapy, Adenocarcinoma, NO, Follow-Up Studie, Internal medicine, advanced non-small-cell lung cancer, medicine, Humans, Lung cancer, Advanced non-small-cell lung cancer, Chemotherapy, Quality of life analysis of TORCH , first-line erlotinib , second-line cisplatin/gemcitabine chemotherapy, advanced non-small-cell lung cancer, Aged, Neoplasm Staging, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Questionnaire, Cancer, Quinazoline, medicine.disease, Interim analysis, Gemcitabine, Surgery, Lung Neoplasm, quality of life, Quinazolines, Carcinoma, Large Cell, Cisplatin, Neoplasm Recurrence, Local, business, Follow-Up Studies
وصف الملف: ELETTRONICO
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297e0496785c9c52225a929dbddaa27eTest
http://hdl.handle.net/11588/519780Test -
7
المؤلفون: Cutsem, E. Van, Dicato, M., Arber, N., Berlin, J., Cervantes, A., Ciardiello, F., Gramont, A. De, Diaz-Rubio, E., Ducreux, M., Geva, R., Glimelius, B., Glynne-Jones, R., Grothey, Axel, Gruenberger, T., Haller, D., Haustermans, K., Labianca, R., Lenz, H. J., Minsky, B., Nordlinger, B., Ohtsu, A., Pavlidis, Nicholas, Rougier, P., Schmiegel, W., Velde, C. Van de, Schmoll, H. J., Sobrero, A., Tabernero, Josep
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]
المصدر: Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO
مصطلحات موضوعية: Oncology, Colorectal cancer, medicine.medical_treatment, Braf protein, Gastroenterology, Metastasis, Drug antagonism, Targeted therapy, Antineoplastic agents, Pathology, Conference paper, Biological markers, Predictive marker, Hematology, Prognosis, Chemotherapy regimen, Antineoplastic agent, Proto-oncogene proteins, Ras protein, Human, Receptor, medicine.medical_specialty, Neoplasm metastasis, Ras proteins, MEDLINE, Oncoprotein, Colorectal neoplasms, Proto-oncogene proteins b-raf, Internal medicine, Genetics, medicine, Humans, Gastrointestinal cancer, Colorectal tumor, B raf kinase, Epidermal growth factor receptor, Kras protein, business.industry, Epidermal growth factor, Cancer, medicine.disease, digestive system diseases, Biological marker, Metabolism, Spain, Mutation, Carcinoembryonic antigen, Microsatellite instability, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbacd7b9ee1ebf6fa145eb7d60aaa564Test
https://doi.org/10.1093/annonc/mdq273Test -
8
المؤلفون: Casali, Paolo G., Bruzzi, P., Bogaerts, Jan, Blay, Jean-Yves, Aapro, M. S., Adamou, A., Berruti, A., Bressington, J., Bruzzi, B., Capocaccia, R., Cardoso, Fatima, Celis, J. E., Cervantes, A., Ciardiello, F., Claussen, C., Coleman, M., Comis, S., Craine, S., Boltz, D. De, Lorenzo, F. De, P, Angelo Dei Tos, Gatta, G., Geissler, J., Giuliani, R., Grande, E., Gronchi, A., Jezdic, S., Jonsson, B., Jost, Lorenz M., Keulen, H., Lacombe, D., Lamory, G., Cam, Y. Le, Priolo, S. Leto di, Licitra, Lisa, Macchia, F., Margulies, A., Marreaud, S., McVie, G., Narbutas, S., Oliver, K., Pavlidis, Nicholas, Pelouchova, J., Pentheroudakis, George, Piccart, M., Pierotti, M. A., Pravettoni, G., Redmond, K., Riegman, P., Ruffilli, M. P., Ryner, D., Sandrucci, S., Seymour, M., Torri, V., Trama, A., Belle, S. Van, Vassal, G., Wartenberg, M., Watts, C., Wilson, A., Yared, W.
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Pentheroudakis, George [0000-0002-6632-2462]
المصدر: Annals of Oncology
مصطلحات موضوعية: Research design, Pathology, Data base, Research methodology, Electronic medical record, Disease, Review, Procedures, Treatment response, Clinical trials, Rare cancers, Clinical Studies as Topic, Humans, Neoplasms, Rare Diseases, Research Design, Hematology, Oncology, Reimbursement, Priority journal, education.field_of_study, Clinical studies as topic, Rare diseases, Europe, Clinical decision making, Human, medicine.medical_specialty, Practice guideline, Case finding, Population, Health care quality, Reviews, Cancer research, Clinical study, SDG 3 - Good Health and Well-being, Conceptual framework, medicine, Tumor marker, Intensive care medicine, education, Antineoplastic activity, Flexibility (engineering), Surrogate endpoint, business.industry, Methodology, Rare cancer, Study design, Cancer survival, Clinical trial, Patient information, Clinical effectiveness, Position paper, Neoplasm, business, Rare disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5a685ea1389f3a5c7803fbf6a7d818Test
https://gnosis.library.ucy.ac.cy/handle/7/41511Test -
9
المؤلفون: Barone, C., Giuliante, F., Adam, R., Pinto, C., Garufi, C., Folprecht, G., Falcone, Alfredo, Nuzzo, G., Van Cutsem, E., Ciardiello, F., Capussotti, L., Poston, G.
المساهمون: Barone, C, Pinto, C, Normanno, N, Capussotti, L, Cognetti, F, Falcone, A, Mantovani, L, Mantovani, LORENZO GIOVANNI
المصدر: PLoS ONE
PLoS ONE, Vol 9, Iss 1, p e85897 (2014)مصطلحات موضوعية: Non-Clinical Medicine, Delphi Technique, Cost effectiveness, Colorectal cancer, Cost-Benefit Analysis, Cancer Treatment, lcsh:Medicine, Cetuximab, Colorectal Neoplasm, medicine.disease_cause, Cost Effectiveness, Antineoplastic Agent, Science Policy and Economics, Neoplasm Metastasis, lcsh:Science, Proto-Oncogene Protein, Multidisciplinary, Cost–benefit analysis, Health Care Costs, Cost-effectiveness analysis, Bevacizumab, Neoplasm Metastasi, Oncology, Italy, metastatic colorectal, Medicine, KRAS, Colorectal Neoplasms, Research Article, medicine.drug, Human, medicine.medical_specialty, KRAS testing, Science Policy, colorectal cancer, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Rectal Cancer, Proto-Oncogene Proteins p21(ras), Health Economics, Proto-Oncogene Proteins, Gastrointestinal Tumors, Cancer Detection and Diagnosis, Early Detection, medicine, Humans, Cost-Benefit Analysi, Intensive care medicine, neoplasms, Settore MED/06 - ONCOLOGIA MEDICA, Biochemistry, Genetics and Molecular Biology (all), business.industry, lcsh:R, kras, Cancers and Neoplasms, Chemotherapy and Drug Treatment, medicine.disease, ras Protein, digestive system diseases, Quality-adjusted life year, Surgery, Health Care Cost, Agricultural and Biological Sciences (all), ras Proteins, cetuximab or bevacizumab, lcsh:Q, Cost-Effectiveness, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2e56049119f186680599d34390986edTest
http://hdl.handle.net/10281/184952Test -
10
المؤلفون: CIARDIELLO, Fortunato, TORTORA G, D'ARMIENTO FP, DE ROSA G, STAIBANO S, AUTORINO R, D'ARMIENTO M, DE LAURENTIIS M, DE PLACIDO S, CATALANO G, BIANCO AR, CIARDIELLO F.
المساهمون: Ciardiello, Fortunato, Tortora, G, D'Armiento, Fp, DE ROSA, G, Staibano, S, Autorino, R, D'Armiento, M, DE LAURENTIIS, M, DE PLACIDO, S, Catalano, G, Bianco, Ar, Ciardiello, F.
المصدر: Scopus-Elsevier
مصطلحات موضوعية: Male, Anticorps monoclonal, business.industry, Cancer therapy, Antibodies, Monoclonal, Antineoplastic Agents, Hematology, Receptor-mediated endocytosis, Drugs, Investigational, Sensitivity and Specificity, Cancer treatment, ErbB Receptors, Survival Rate, Clinical Trials, Phase II as Topic, Treatment Outcome, Oncology, Clinical Trials, Phase III as Topic, Epidermal growth factor, Neoplasms, Cancer research, Medicine, Humans, Female, Immunotherapy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8902d01286db26c27f3c34114f86d8Test
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036433244&partnerID=MN8TOARSTest